Company Profile
Year Established :
1976
Total Assets(USD) :
250,000,000 To 499,999,999
Total Number of Staff :
less than 10 person
Main Competitive Advantages :
Brandname,International Approvals/Standards,Delivery Term,Production capacity,Quality Service
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
choose not to disclose
Main Sales Markets :
Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Bio Products
Zhejiang Share Bio-Pharm Co.,Ltd. is an subsidiary of Zhejiang Dayang Biotech Group Co.,Ltd. The company mainly focus on the marketing and sales of the API, Chemical products, Intermediates, Feed additives, Finished products, Food additives etc.
API: AMPROLIUM HCL, FOSFOMYCIN SODIUM, FOSFOMYCIN CALCIUM, CEFTIOFUR SODIUM, CEFTIOFUR HCL, CEFQUINOME SULPHATE, FOSFOMYCIN SODIUM, FOSFOMYCIN CALCIUM, AMOXICILLIN, AMPICILLIN, PRAZIQUANTEL, TILMICOSIN PHOSPHATE, NEOMYCIN SULFATE. Premix: Enramycin 4%, Enramycin 8%, Colistin sulfate 10%, Avilamycin 10%/20%; Food additive: Potassium carbonate, Potassium bicarbonate, Potassium chloride,Ammonium chloride, INTERMEDIATE：2-Chloro-6-Fluorobenzaldehyde, 2-Chloro-6-fluorobenzyl chloride, etc
Thirteen years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
